维普期刊资源整合服务平台（V6.5）

82篇 您的检索式：作者名="YASAR U"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Pharmacokinetics of losartan and its metabolite E- 3174 in relation to the CYP2C9 genotype显示文摘	Yasar U	2002	Clinical Pharmacology Therapeutics2002，71，1：	1
2	Pharmacokinetics of losartan and its metabolite E-3174 in relation tothe CYP2C9 genotype 显示文摘	YASAR U FORSLUND-BERGENGREN C TYBRING G	2002	Clin Pharmacol Ther2002，71，1：	1
3	Role of CYP2C9 polymorphism in losartan oxidation 显示文摘	Yasar U Tybring G Hidestrand M	2001	Drug Metab Dispos2001，29，7：	1
4	Deferoxamine and meropenem combination therapy in experimental acute pancreatitis 显示文摘	Ateskan U Mas MR Yasar M	2003	Pancreas2003，27，3：	1
5	Role of Polymorphic human CYP2B6 in cyclophosphamide bioactivation 显示文摘	Xie HJ Yasar U Lundgren S	2003	Pharmacogenomics J2003，3，1：	1
6	Comparison of shaping a- bility of RaCe and Hero Shaper instruments in simulated curved canals 显示文摘	Aydin C Inan U Yasar S	2008	Oral Surg Oral Med Oral Pathol Oral Ra- diol Endod2008，105，3：	1
7	Deferoxamine and meropen- em combination therapy in experimental acute pancreatitis显示文摘	Ateskan U Mas MR Yasar M	2003	Pancreas2003，27，3：	1
8	Functional and clinical evaluateon for the surgical treatment of degenerative stenosis of the lumbar spinal canal显示文摘	Yasar B Simsek S Er U	2009	J Neurosurg Spine2009，11，3：	1
9	Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype 显示文摘	YASAR U FORSLUND-BERGENGREN C TYBRING G	2002	Clin Pharrtuwol Ther2002，71，1：	1
10	The role of CYP2C9 genotype in the metabolism of diclofenac in vivo and in vitro显示文摘	YASAR U ELIASSON E FORSLUND-BERGENGREN C	2001	EurJ Clin Pharmacol2001，57，10：	1
11	Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population 显示文摘	Yasar U Eliasson E Dahl ML	1999	Biochem Biophys Res Commun1999，254，3：	1
12	Penetration of Meropenem and Cefepim into Pancreatic Tissue During the Course of Experirnental Acute Panereatitis显示文摘	Saglamkaya U Mas MR Yasar M	2002	Pancreas2002，，24：	1
13	Phamlacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype显示文摘	Yasar U Forslund-Bergengren C Tybring G	2002	Clin Pharmacol Ther2002，71，1：	1
14	Genetic polymorphisan of cy- tochrome P450 2C9 in a Caucasian and a Black African population显示文摘	Scordo MG Aklillu E Yasar U	2001	Br J Clin Pharmacol2001，52，4：	1
15	Role of CYP2C9 polymorphism in losartan oxidation 显示文摘	Yasar U Tybring G Hidestrand M	2001	Drug Metab Dispos2001，29，7：	1
16	Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population 显示文摘	Yasar U Eliasson E Dahl ML	1999	Biochem Biophys Res Commun1999，254，3：	1
17	Deferoxamine and meropenem combination therapy in experimental acute pancreatitis显示文摘	Ateskan U Mas MR Yasar M	2003	Pancreas2003，27，3：	1
18	Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction显示文摘	Yasar U Bennet AM Eliasson E	2003	Pharmacogenetics2003，13，：	1
19	Deferoxamine and mero- penem combination therapy in experimental acute paneretitis 显示文摘	Ateskan U Mas MR Yasar M	2003	Pancreas2003，27，3：	1
20	Validation of methods for CYP2C9 genotyping:frequencies of mutant alleles in a Swedish population显示文摘	Yasar U Eliasson E Dahl ML	1999	Biochem Biophys Res Commun1999，254，3：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示